中国全科医学2017，Vol.20Issue(27)：3323-3327,5.DOI:10.3969/j.issn.1007-9572.2017.06.y53
中性粒细胞明胶酶相关脂质运载蛋白与心血管疾病相关性的研究进展
Recent Developments in Neutrophil Gelatinase-Associated Lipocalin and Cardiovascular Disease
摘要
Abstract
Cardiovascular disease(CVD)seriously endangers public health.Therefore,it is of great significance to study the predictive markers of CVD.Recent studies showed that neutrophil gelatinase-associated lipocalin (NGAL) is an important marker for CVD.NGAL is directly involved in the pathogensis of CVD,and it also can independently predict the prognosis of acute myocardial infarction(AMI)and heart failure (HF).In this paper,the recent studies on NGAL and coronary heart disease (CHD),NGAL and AMI,NGAL and HF were respectively summarized and analyzed.We concluded that NGAL has clinical value in evaluating the severity of CVD and predicting the prognosis of CVD.关键词
心血管疾病/中性粒细胞明胶酶相关脂质运载蛋白/冠心病/心肌梗死/心力衰竭Key words
Cardiovascular diseases/Neutrophil gelatinase-associated lipocalin/Coronary disease/Myocardial infarction/Heart failure分类
医药卫生引用本文复制引用
陈文,朱继红..中性粒细胞明胶酶相关脂质运载蛋白与心血管疾病相关性的研究进展[J].中国全科医学,2017,20(27):3323-3327,5.基金项目
北京市科技计划项目(Z161100000516045) （Z161100000516045）
